Galectin-3 (Gal-3) is a beta-galactoside-binding protein that has been associated with chronic inflammation and fibrogenesis and has been shown to play a role in the severity of NASH (91). Here, LGALS3 is linked to metabolic dysfunction-associated steatohepatitis.